Mymetics Corp (MYMX)

[Work Harder]

Three new executives are joining Tollys president Jacques-François Martin on the board of directors

https://www.life-sciences-france.com/news/tollys-closes-series-financing-andrew-lloyd-associates-ala-2001-116843.html

Jacques-François Martin

President Co-Founder

http://tollys.fr/board-of-directors/

Dr Vincent Charlon

Managing Director Ceo

http://tollys.fr/management-2/

Dr. Dino Dina, is a scientific advisors of Tollys. He served as President of Dynavax Technologies

http://tollys.fr/dino-dina/

Shares of Dynavax Technologies (NASDAQ:DVAX) jumped 26.4% on Friday following comments by researchers at Sinovac, a Chinese drug developer that's collaborating with Dynavax on a COVID-19 vaccine.

https://www.fool.com/investing/2020/05/29/dynavax-stock-soars-264-today-on-covid-19-vaccine.aspx

Dynavax is contributing an adjuvant that can boost immune responses in vaccinated patients, while Sinovac is contributing an inactivated coronavirus vaccine candidate.

Dynavax's adjuvant is a synthetic form of DNA that is already used in Dynavax's approved hepatitis B vaccine, Heplisav-B, but that doesn't guarantee it will be similarly effective in helping Sinovac's COVID-19 vaccine succeed.